Efficacy and Safety Study of ESBA1008 Versus EYLEA®

Clinical trial NCT01796964 · COMPLETED

Trial details

NCT number: NCT01796964
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exudative Age-Related Macular Degeneration

Start date: 2013-03-01
Primary completion: 2013-10-01
Enrollment: 173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.